Boehringer Ingelheim and Vétérinaires sans Frontières Germany fight rabies in Kenya
Boehringer Ingelheim launches EURICAN® L4 vaccine, offering outstanding protection against leptospirosis in dogs
Boehringer Ingelheim launches VETMEDIN® Solution (pimobendan oral solution), first oral solution approved by the FDA for congestive heart failure in dogs
Focus on Health Equity drives upgrade in Access to Medicine Index Ranking
Collaboration with Mary Tyler Moore Vision Initiative
Developing treatments for people with mental health conditions
Boehringer Ingelheim and WHO Foundation join forces to promote equitable access to healthcare
Boehringer Ingelheim collaborates with Circle Pharma
Boehringer receives U.S. FDA Breakthrough Therapy designation and initiates two phase III trials in MASH for survodutide
Boehringer Ingelheim partners with NCD Alliance to target Non-Communicable Diseases in underserved communities
Boehringer Ingelheim expands cancer research at its Vienna site
Nerandomilast meets primary endpoint in pivotal phase-III FIBRONEER™-IPF study
Media Contacts
Head of Global Media Relations
E-Mail:
harro.ten_wolde@boehringer-ingelheim.com
Phone Number:
+49 (6132) 77-181352
Senior Media Relations Manager
E-Mail:
tereza.urbankova@boehringer-ingelheim.com
Phone Number:
+49 (6132) 77-184817
Senior Media Relations Manager
E-Mail:
mark_william.valentiner@boehringer-ingelheim.com
Tel.: +49 (6132) 77-170136
Media Relations Manager
E-Mail:
valerie-chiara.nestle@boehringer-ingelheim.com
Phone Number:
+49 (7351) 54-175075
Head of Human Pharma Communications
E-Mail:
anthonia.aboyeji@boehringer-ingelheim.com
Phone Number:
+49 (6132) 77-172370
Head of Animal Health Communications
E-Mail:
Heidi.DeWit-Sommerfeld@boehringer-ingelheim.com
Phone Number:
+49 (6132) 77-171799
Head of Innovation Unit Communications
E-Mail: camilla.krogh_lauritzen@boehringer-ingelheim.com
Phone Number: +45 2272 4806